The analysis for CSF IgM binding to HOG cells among MS subgroups and control showed a statistically significant difference in binding between control and RRMS, control and SPMS, and CIS and SPMS subgroups (Fig. 4D). This evidence concerns the gene CD40LG and in situ carcinoma.